Delphine Desjardins

11PUBLICATIONS
50CO-AUTHORS
Semi- and unsupervised learningMedical virologyDisease surveillanceInnate immunityPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 21, 2026
Constitutive natural killer cell features associated with post-treatment control of SIV infection in the pVISCONTI study.

|Feb 27, 2026
Post-treatment SIV control is associated with specific features of viral persistence before and after treatment interruption.

Caroline Charre, Adeline Melard, Antoine Chaillon

|Feb 24, 2026
Maintenance of intestinal CX3CR1+ macrophage homeostasis defines post-treatment control in SIV-infected macaques.

Stéphane Hua, Keltouma Benmeziane, Delphine Desjardins

|Jan 11, 2024
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells.

Caroline Passaes, Delphine Desjardins, Anaïs Chapel

|Oct 06, 2023
Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure.

Karunasinee Suphaphiphat, Delphine Desjardins, Valérie Lorin

|Nov 11, 2022
Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates.

Thibaut Gelé, Hélène Gouget, Nathalie Dereuddre-Bosquet

Pageof 2

Frequent Collaborators

9 joint publications

Roger Le Grand

7 joint publications

Nathalie Dereuddre-Bosquet

5 joint publications

Véronique Avettand-Fenoel

4 joint publications

Adeline Mélard